nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
360 A case series of thrombotic and thromboembolic complications of central venous access in cystic fibrosis patients
|
Kandamany, N. |
|
2012 |
11 |
Supplement 1 |
p. S149- 1 p. |
artikel |
2 |
322 Advances in transition: multi-level factors associated with adult achievement
|
Barto, T.L. |
|
2012 |
11 |
Supplement 1 |
p. S139- 1 p. |
artikel |
3 |
A fat lot of good: Balance and trends in fat intake in children with cystic fibrosis
|
Smith, C. |
|
2012 |
11 |
Supplement 1 |
p. 154-157 4 p. |
artikel |
4 |
A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis
|
Reeves, Emer P. |
|
2012 |
11 |
Supplement 1 |
p. 100-107 8 p. |
artikel |
5 |
6 A novel StripAssay for the detection of cystic fibrosis mutations in the Turkish population
|
Puehringer, H. |
|
2012 |
11 |
Supplement 1 |
p. S56- 1 p. |
artikel |
6 |
242 Are we missing salt depletion in cystic fibrosis?
|
Sharp, S. |
|
2012 |
11 |
Supplement 1 |
p. S118- 1 p. |
artikel |
7 |
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic
|
Griffiths, Amanda L. |
|
2012 |
11 |
Supplement 1 |
p. 49-52 4 p. |
artikel |
8 |
47 Bronchitol (inhaled dry powder mannitol) in adult patients with cystic fibrosis
|
Aitken, M. |
|
2012 |
11 |
Supplement 1 |
p. S68- 1 p. |
artikel |
9 |
274 CF experience for respiratory trainees in the UK
|
Nazareth, D. |
|
2012 |
11 |
Supplement 1 |
p. S127- 1 p. |
artikel |
10 |
288 CF patients with totally implantable venous access devices (TIVAD): prospective survey of Doppler-US (DUS) central venous thrombosis (CVT) and thrombophilia (TB) assessment
|
Munck, A. |
|
2012 |
11 |
Supplement 1 |
p. S130- 1 p. |
artikel |
11 |
166 CF sputum rheology and the role of the airway mucin MUC5AC
|
Horsley, A. |
|
2012 |
11 |
Supplement 1 |
p. S99- 1 p. |
artikel |
12 |
Clinical evidence that V456A is a Cystic Fibrosis causing mutation in South Asians
|
Uppaluri, L. |
|
2012 |
11 |
Supplement 1 |
p. 312-315 4 p. |
artikel |
13 |
305 Comparison of contacts to adult and paediatric cystic fibrosis Clinical Nurse Specialists
|
Butler, M. |
|
2012 |
11 |
Supplement 1 |
p. S135- 1 p. |
artikel |
14 |
214 Core competencies for physiotherapists working with cystic fibrosis patients in Italy
|
Tartali, C. |
|
2012 |
11 |
Supplement 1 |
p. S111- 1 p. |
artikel |
15 |
20 Cystic fibrosis newborn screening in Italy: survey for assessment of technical-scientific and organizational issues
|
Repetto, T. |
|
2012 |
11 |
Supplement 1 |
p. S60- 1 p. |
artikel |
16 |
Cystic fibrosis research in allied health and nursing professions
|
Bradley, Judy M. |
|
2012 |
11 |
Supplement 1 |
p. 387-392 6 p. |
artikel |
17 |
Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation
|
Hofer, Markus |
|
2012 |
11 |
Supplement 1 |
p. 131-136 6 p. |
artikel |
18 |
319 Do symptoms of depression determine the course of lung function in patients with cystic fibrosis?
|
Fidika, A. |
|
2012 |
11 |
Supplement 1 |
p. S138- 1 p. |
artikel |
19 |
111 Epidemiology and species distribution of Burkholderia cepacia complex in Ireland. A 10 year review
|
Collins, J. |
|
2012 |
11 |
Supplement 1 |
p. S84- 1 p. |
artikel |
20 |
239 Establishment of an F508del pseudoislet model for the study of CF-related diabetes
|
McClenaghan, N.H. |
|
2012 |
11 |
Supplement 1 |
p. S117- 1 p. |
artikel |
21 |
152 Estrogen-regulated MicroRNAs control the expression of secretory leukoprotease inhibitor in monocytes
|
McKiernan, P. |
|
2012 |
11 |
Supplement 1 |
p. S95- 1 p. |
artikel |
22 |
197 Evaluation of aerobic exercise capacity and daily functioning of patients with cystic fibrosis
|
Eisenstadt, I. |
|
2012 |
11 |
Supplement 1 |
p. S107- 1 p. |
artikel |
23 |
270 Factors associated with vitamin K deficiency in adults with cystic fibrosis
|
Ochota, A. |
|
2012 |
11 |
Supplement 1 |
p. S125- 1 p. |
artikel |
24 |
108 First identification of non-lactose fermenting Gram negative respiratory isolates from an Irish cystic fibrosis population using matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS)
|
Prior, A.-R. |
|
2012 |
11 |
Supplement 1 |
p. S84- 1 p. |
artikel |
25 |
149 Gibberellin induces the NF-úB inhibitor A20 in airway epithelial cells
|
Schock, B.C. |
|
2012 |
11 |
Supplement 1 |
p. S94- 1 p. |
artikel |
26 |
33 Hypoxia reduces internalization of Pseudomonas aeruginosa in pulmonary epithelial cells
|
Schaible, B. |
|
2012 |
11 |
Supplement 1 |
p. S64- 1 p. |
artikel |
27 |
IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis
|
Derycke, L. |
|
2012 |
11 |
Supplement 1 |
p. 193-200 8 p. |
artikel |
28 |
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice
|
Lubamba, Bob |
|
2012 |
11 |
Supplement 1 |
p. 266-273 8 p. |
artikel |
29 |
183 Impact of progression of cystic fibrosis lung disease on quality of life
|
Tepper, L.A. |
|
2012 |
11 |
Supplement 1 |
p. S103- 1 p. |
artikel |
30 |
80 Investigation of the potential mechanisms of antibiotic resistance in the cystic fibrosis pathogen, Burkholderia cepacia complex
|
Kennedy, S. |
|
2012 |
11 |
Supplement 1 |
p. S77- 1 p. |
artikel |
31 |
135 Is the lung of cystic fibrosis patients a reservoir of extended-spectrum beta-lactamase-producing Enterobacteriaceae?
|
Fiscarelli, E. |
|
2012 |
11 |
Supplement 1 |
p. S90- 1 p. |
artikel |
32 |
200 Long inhalation time is associated with short treatment time when using the I-neb AAD System in target inhalation mode
|
Spencer, T. |
|
2012 |
11 |
Supplement 1 |
p. S107- 1 p. |
artikel |
33 |
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
|
Ren, Clement L. |
|
2012 |
11 |
Supplement 1 |
p. 293-299 7 p. |
artikel |
34 |
58 No antibiotic cross-resistance after 1 year of continuous aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients (pts) with chronic Burkholderia (BURK) infection
|
Burns, J. |
|
2012 |
11 |
Supplement 1 |
p. S71- 1 p. |
artikel |
35 |
PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak
|
Dedeckova, Klara |
|
2012 |
11 |
Supplement 1 |
p. 440-445 6 p. |
artikel |
36 |
125 Presence of Pandoraea and Herbaspirillum species within the Irish CF population
|
Collins, J. |
|
2012 |
11 |
Supplement 1 |
p. S88- 1 p. |
artikel |
37 |
229 Prucalopride: a review of the first 12 months of use
|
Williams, K. |
|
2012 |
11 |
Supplement 1 |
p. S115- 1 p. |
artikel |
38 |
Qualitative analysis of parent experiences with achieving cystic fibrosis nutrition recommendations
|
Filigno, Stephanie S. |
|
2012 |
11 |
Supplement 1 |
p. 125-130 6 p. |
artikel |
39 |
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus
|
Hillman, Magnus |
|
2012 |
11 |
Supplement 1 |
p. 144-149 6 p. |
artikel |
40 |
77 Risk factor of multi-drug resistant Pseudomonas aeruginosa (MDR-PA) emergence in cystic fibrosis patients
|
Patout, M. |
|
2012 |
11 |
Supplement 1 |
p. S76- 1 p. |
artikel |
41 |
Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation
|
Mainz, J.G. |
|
2012 |
11 |
Supplement 1 |
p. 158-161 4 p. |
artikel |
42 |
Smoking prevention and cessation programme in cystic fibrosis: Integrating an environmental health approach
|
Ortega-García, Juan Antonio |
|
2012 |
11 |
Supplement 1 |
p. 34-39 6 p. |
artikel |
43 |
94 Statins, a widely used cholesterol-lowering drug, modulate key virulence behaviour of Pseudomonas aeruginosa
|
Hennessy, E. |
|
2012 |
11 |
Supplement 1 |
p. S80- 1 p. |
artikel |
44 |
23 Sweat testing in a tertiary clinic – reasons, results and methodology
|
Mense, L. |
|
2012 |
11 |
Supplement 1 |
p. S61- 1 p. |
artikel |
45 |
332 The prevalence of eating disordered attitudes and behaviour in the cystic fibrosis lung transplant population
|
Mohan, K. |
|
2012 |
11 |
Supplement 1 |
p. S141- 1 p. |
artikel |
46 |
346 The prevalence of F508del and its relation to clinical manifestation in CF patients from Albania
|
Vevecka, E. |
|
2012 |
11 |
Supplement 1 |
p. S145- 1 p. |
artikel |
47 |
1 The role of CFTR genetic testing in diagnosis of cystic fibrosis
|
Fustik, S. |
|
2012 |
11 |
Supplement 1 |
p. S55- 1 p. |
artikel |
48 |
256 The use of high energy milk formula for alimentary status correction in children with cystic fibrosis (CF)
|
Roslavtseva, E. |
|
2012 |
11 |
Supplement 1 |
p. S122- 1 p. |
artikel |
49 |
63 Time to recurrence and antimicrobial susceptibility of first-time detected Achromobacter xylosoxidans in respiratory tract specimens from patients with cystic fibrosis
|
Wang, M. |
|
2012 |
11 |
Supplement 1 |
p. S72- 1 p. |
artikel |
50 |
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis
|
Hulzebos, H.J. |
|
2012 |
11 |
Supplement 1 |
p. 550-554 5 p. |
artikel |
51 |
WS16.5 Airway clearance therapy and exercise in cystic fibrosis: patients’ perceptions versus participation
|
Kennedy, F. |
|
2012 |
11 |
Supplement 1 |
p. S36- 1 p. |
artikel |
52 |
WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection
|
Goldman, M. |
|
2012 |
11 |
Supplement 1 |
p. S12- 1 p. |
artikel |
53 |
WS9.5 CF epithelial cells are a source of pulmonary cathepsin S via increased IRF-1
|
Weldon, S. |
|
2012 |
11 |
Supplement 1 |
p. S20- 1 p. |
artikel |
54 |
WS8.6 Decision algorithm and scoring method for the classification of variants of unknown clinical significance in the CFTR gene
|
Raynal, C. |
|
2012 |
11 |
Supplement 1 |
p. S17- 1 p. |
artikel |
55 |
WS11.6 Environmental Burkholderia cenocepacia strains can disrupt epithelial integrity in bronchial epithelial cells in vitro and have a more profound effect on ZO-1 in CF cells
|
Bevivino, A. |
|
2012 |
11 |
Supplement 1 |
p. S25- 1 p. |
artikel |
56 |
WS10.1 Evaluation of musculoskeletal and postural function in cystic fibrosis using a physiotherapy screening tool
|
Button, B.M. |
|
2012 |
11 |
Supplement 1 |
p. S22- 1 p. |
artikel |
57 |
WS23.4 High Rhinovirus burden in lower airways of children with cystic fibrosis
|
Kieninger, E. |
|
2012 |
11 |
Supplement 1 |
p. S51- 1 p. |
artikel |
58 |
WS17.8 Inhibition of leukotriene B4 signaling by alpha-1 antitrypsin: support for the use of aerosolized alpha-1 antitrypsin therapy in cystic fibrosis
|
O'Dwyer, C.A. |
|
2012 |
11 |
Supplement 1 |
p. S39- 1 p. |
artikel |
59 |
WS2.1 Investigation of MiRNA regulation of ER stress in cystic fibrosis airway epithelium
|
Oglesby, I.K. |
|
2012 |
11 |
Supplement 1 |
p. S3- 1 p. |
artikel |
60 |
WS10.4 Length of hospital stay and changed weekend physiotherapy cystic fibrosis service
|
Moran, F.C. |
|
2012 |
11 |
Supplement 1 |
p. S22- 1 p. |
artikel |
61 |
WS6.3 Measures of nutritional status in two Phase 3 trials of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR mutation
|
Borowitz, D. |
|
2012 |
11 |
Supplement 1 |
p. S13- 1 p. |
artikel |
62 |
WS17.1 Modulation of inflammatory mediators associated with cystic fibrosis by alpha-1 antitrypsin
|
Bergin, D.A. |
|
2012 |
11 |
Supplement 1 |
p. S38- 1 p. |
artikel |
63 |
WS12.2 Outcomes of patients with cystic fibrosis admitted to an intensive care unit
|
Markewitz, B. |
|
2012 |
11 |
Supplement 1 |
p. S27- 1 p. |
artikel |
64 |
WS18.2 Persistent elevation of antibodies against Pseudomonas aeruginosa following successful eradication?
|
Kappler, M. |
|
2012 |
11 |
Supplement 1 |
p. S41- 1 p. |
artikel |
65 |
WS23.1 Progression of lung disease within specific genotypes of patients with cystic fibrosis (CF) – Which lung function parameter differentiates best?
|
Gallati, S. |
|
2012 |
11 |
Supplement 1 |
p. S51- 1 p. |
artikel |
66 |
WS20.4 Real-time PCR (RT-PCR) provides a “window of opportunity”: optimal screening of patients with cystic fibrosis (CF) through an earlier detection of Pseudomonas aeruginosa (PA)
|
Hérv-Arnaud, G. |
|
2012 |
11 |
Supplement 1 |
p. S45- 1 p. |
artikel |
67 |
WS17.9 The B lymphocyte differentiation factor, BAFF, is expressed in the lung of cystic fibrosis patients and in a mouse model of Pseudomonas aeruginosa infection
|
Saint, G. |
|
2012 |
11 |
Supplement 1 |
p. S40- 1 p. |
artikel |
68 |
WS3.6 The CF-ABLE score: a novel clinical prediction tool in cystic fibrosis
|
McCarthy, C. |
|
2012 |
11 |
Supplement 1 |
p. S7- 1 p. |
artikel |
69 |
WS1.6 The need of an appropriate diagnosis of gastroesophageal reflux disease in cystic fibrosis patients: impact on clinical management
|
Alghisi, F. |
|
2012 |
11 |
Supplement 1 |
p. S2- 1 p. |
artikel |